Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Clinical trial NCT05363280 · RECRUITING

Trial details

NCT number: NCT05363280
Sponsor: Advenchen Pharmaceuticals, LLC.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Renal Cell Carcinoma (RCC)Non-Small Cell Lung

Start date: 2022-11-01
Primary completion: 2027-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.